Barclays analyst Brandon Oglenski lowered the firm’s price target on RXO Inc. (RXO) to $15 from $17 and keeps an Overweight rating on the shares post the Q3 report. The company’s Q4 outlook is materially below expectations and sets up for a fourth year in 2026 of trough level earnings forecasts, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXO: